BIOMAT Database Logo BIOMAT Database Logo

Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells. 2010

Soo Jeong Choi, and Myoung Ju Moon, and So Deok Lee, and Sang-Un Choi, and Sun-Young Han, and Yong-Chul Kim
Department of Life Science, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea.

Indirubin derivatives were identified as potent FLT3 tyrosine kinase inhibitors with anti-proliferative activity at acute myeloid leukemic cell lines, RS4;11 and MV4;11 which express FLT3-WT and FLT3-ITD mutation, respectively. Among several 5 and 5'-substituted indirubin derivatives, 5-fluoro analog, 13 exhibited potent inhibitory activity at FLT3 (IC(50)=15 nM) with more than 100-fold selectivity versus 6 other kinases and potent anti-proliferative effect for MV4;11 cells (IC(50)=72 nM) with 30-fold selectivity versus RS4;11 cells. Cell cycle analysis indicated that compound 13 induced cell cycle arrest at G(0)/G(1) phase in MV4;11 cells.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Soo Jeong Choi, and Myoung Ju Moon, and So Deok Lee, and Sang-Un Choi, and Sun-Young Han, and Yong-Chul Kim
Discovery of indirubin-3'-aminooxy-acetamide derivatives as potent and selective FLT3/D835Y mutant kinase inhibitors for acute myeloid leukemia.
July 2022, European journal of medicinal chemistry,
Soo Jeong Choi, and Myoung Ju Moon, and So Deok Lee, and Sang-Un Choi, and Sun-Young Han, and Yong-Chul Kim
Anti-leukemic Activity of AIU2008 in FLT3-ITD-positive Acute Myeloid Leukemia.
February 2021, Anticancer research,
Soo Jeong Choi, and Myoung Ju Moon, and So Deok Lee, and Sang-Un Choi, and Sun-Young Han, and Yong-Chul Kim
Discovery of novel benzimidazole derivatives as potent p300 bromodomain inhibitors with anti-proliferative activity in multiple cancer cells.
July 2022, Bioorganic & medicinal chemistry,
Soo Jeong Choi, and Myoung Ju Moon, and So Deok Lee, and Sang-Un Choi, and Sun-Young Han, and Yong-Chul Kim
Investigation of Selected Flavonoid Derivatives as Potent FLT3 Inhibitors for the Potential Treatment of Acute Myeloid Leukemia.
January 2021, Journal of natural products,
Soo Jeong Choi, and Myoung Ju Moon, and So Deok Lee, and Sang-Un Choi, and Sun-Young Han, and Yong-Chul Kim
Discovery of quinolinone derivatives as potent FLT3 inhibitors.
March 2014, Biochemical and biophysical research communications,
Soo Jeong Choi, and Myoung Ju Moon, and So Deok Lee, and Sang-Un Choi, and Sun-Young Han, and Yong-Chul Kim
5,5'-substituted indirubin-3'-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity.
May 2010, Journal of medicinal chemistry,
Soo Jeong Choi, and Myoung Ju Moon, and So Deok Lee, and Sang-Un Choi, and Sun-Young Han, and Yong-Chul Kim
Discovery of novel 4-azaaryl-N-phenylpyrimidin-2-amine derivatives as potent and selective FLT3 inhibitors for acute myeloid leukaemia with FLT3 mutations.
March 2021, European journal of medicinal chemistry,
Soo Jeong Choi, and Myoung Ju Moon, and So Deok Lee, and Sang-Un Choi, and Sun-Young Han, and Yong-Chul Kim
Discovery of benzimidazole-indazole derivatives as potent FLT3-tyrosine kinase domain mutant kinase inhibitors for acute myeloid leukemia.
December 2023, European journal of medicinal chemistry,
Soo Jeong Choi, and Myoung Ju Moon, and So Deok Lee, and Sang-Un Choi, and Sun-Young Han, and Yong-Chul Kim
Discovery of FLT3-targeting PROTACs with potent antiproliferative activity against acute myeloid leukemia cells harboring FLT3 mutations.
March 2024, European journal of medicinal chemistry,
Soo Jeong Choi, and Myoung Ju Moon, and So Deok Lee, and Sang-Un Choi, and Sun-Young Han, and Yong-Chul Kim
Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases.
January 2015, Evidence-based complementary and alternative medicine : eCAM,
Copied contents to your clipboard!